SBBP insider transactions
Strongbridge Biopharma plc (SBBP) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for SBBP
- SEC Form 4: Cdk Associates, L.L.C. disposed of 8,060,682 units of Ordinary Shares4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4: Wilhoit Scott L. returned 109,510 units of Ordinary Shares to the company, closing all direct ownership in the company4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4: Kollender Richard S returned 234,229 units of Ordinary Shares to the company, closing all direct ownership in the company4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4: Cohen Fredric J. returned 160,408 units of Ordinary Shares to the company, decreasing direct ownership by 50% to 160,408 units4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4: Johnson John returned 610,092 units of Ordinary Shares to the company, closing all direct ownership in the company4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4: Steineger Hilde H returned 64,258 units of Ordinary Shares to the company, closing all direct ownership in the company4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4: Steen Marten returned 64,151 units of Ordinary Shares to the company4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4: Sherman Jeffrey W returned 64,258 units of Ordinary Shares to the company, closing all direct ownership in the company4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4: Kong Garheng returned 63,993 units of Ordinary Shares to the company, closing all direct ownership in the company4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4: Gill David N returned 78,058 units of Ordinary Shares to the company, closing all direct ownership in the company4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4: Long Stephen J returned 117,793 units of Ordinary Shares to the company, closing all direct ownership in the company4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4: Wilhoit Scott L. covered exercise/tax liability with 27,515 units of Ordinary Shares, decreasing direct ownership by 20% to 109,510 units4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4: Long Stephen J covered exercise/tax liability with 49,307 units of Ordinary Shares, decreasing direct ownership by 30% to 117,793 units4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4: Kollender Richard S covered exercise/tax liability with 64,791 units of Ordinary Shares, decreasing direct ownership by 22% to 234,229 units4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4: Cohen Fredric J. covered exercise/tax liability with 51,548 units of Ordinary Shares, decreasing direct ownership by 24% to 160,408 units4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4: Steen Marten covered exercise/tax liability with 17,763 units of Ordinary Shares4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4: Johnson John covered exercise/tax liability with 334,868 units of Ordinary Shares, decreasing direct ownership by 35% to 610,092 units4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4: Steineger Hilde H covered exercise/tax liability with 17,763 units of Ordinary Shares, decreasing direct ownership by 22% to 64,258 units4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4: Sherman Jeffrey W covered exercise/tax liability with 17,763 units of Ordinary Shares, decreasing direct ownership by 22% to 64,258 units4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4: Kong Garheng covered exercise/tax liability with 17,763 units of Ordinary Shares, decreasing direct ownership by 22% to 63,993 units4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4: Gill David N covered exercise/tax liability with 17,763 units of Ordinary Shares, decreasing direct ownership by 19% to 78,058 units4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4: Kollender Richard S covered exercise/tax liability with 17,088 units of Ordinary Shares, decreasing direct ownership by 5% to 299,020 units4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4 filed by Strongbridge Biopharma plc4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4: Steineger Hilde H was granted 40,000 units of Ordinary Shares, increasing direct ownership by 95% to 82,021 units4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4: Steen Marten was granted 40,000 units of Ordinary Shares4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4: SHERMAN JEFFREY W was granted 40,000 units of Ordinary Shares, increasing direct ownership by 95% to 82,021 units4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4: Kong Garheng was granted 40,000 units of Ordinary Shares, increasing direct ownership by 96% to 81,756 units4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4: GILL DAVID N was granted 40,000 units of Ordinary Shares, increasing direct ownership by 72% to 95,821 units4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4: Kollender Richard S disposed of $25,974 worth of Ordinary Shares (11,392 units at $2.28), decreasing direct ownership by 3% to 316,108 units4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4: Steineger Hilde H disposed of $44,518 worth of Ordinary Shares (18,944 units at $2.35), decreasing direct ownership by 31% to 42,021 units4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4: John Johnson disposed of $46,431 worth of Ordinary Shares (17,325 units at $2.68), decreasing direct ownership by 2% to 995,827 units4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4: S Richard Kollender was granted 80,000 units of Ordinary Shares, increasing direct ownership by 32% to 327,500 units4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4: L. Scott Wilhoit disposed of $25,778 worth of Ordinary Shares (7,121 units at $3.62), decreasing ownership by 5% to 137,025 units4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4: Matthew Robert Lutz disposed of $25,260 worth of Ordinary Shares (6,978 units at $3.62), decreasing ownership by 4% to 181,333 units4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4: J Stephen Long disposed of $25,564 worth of Ordinary Shares (7,062 units at $3.62), decreasing ownership by 4% to 167,100 units4 - Strongbridge Biopharma plc (0001634432) (Issuer)
- SEC Form 4: J. Fredric Cohen disposed of $25,260 worth of Ordinary Shares (6,978 units at $3.62), decreasing ownership by 3% to 211,956 units4 - Strongbridge Biopharma plc (0001634432) (Issuer)